alexa Scleroderma Lung Fibrosis and Biologic Drugs | OMICS International | Abstract
ISSN: 2161-1149

Rheumatology: Current Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Scleroderma Lung Fibrosis and Biologic Drugs

Paola Caramaschi*, Domenico Biasi, Sara Pieropan, Cinzia Scambi and Silvano Adami

Rheumatology Unit, Department of Medicine, University of Verona, Italy

*Corresponding Author:
Paola Caramaschi
Unità di Reumatologia
P.le Scuro, 37134 Verona, Italy
Tel: 0039 45 8124049
Fax: 0039 45 8126881
E-mail: [email protected]

Received Date: October 24, 2011; Accepted Date: November 23, 2011; Published Date: November 25, 2011

Citation: Caramaschi P, Biasi D, Pieropan S, Scambi C, Adami S (2011) Scleroderma Lung Fibrosis and Biologic Drugs. Rheumatology S1:001. doi: 10.4172/2161-1149.S1-001

Copyright: © 2011 Caramaschi P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Biologic agents have revolutionized the management of some inflammatory diseases like rheumatoid arthritis, seronegative spondyloarthropathies and Crohn’s disease; the selective inhibition of mediators involved in systemic chronic processes have allowed to expand the knowledge among the complex pathogenic pathways that are involved in inflammation and damage. The off-label use of biologic drugs is expanding.

This review highlights the theoretical basis that may support the use of biologic drugs in the treatment of Systemic Sclerosis (SSc), a disabling and sometimes devastating disease whose treatment remains largely unsatisfactory. Some progresses have been made concerning the vascular complications of the disease, but the skin and visceral fibrosis, which is the hallmark of the disease, is still orphan of effective therapy. Moreover the results of the limited clinical experience about biologic agent administration in SSc and SSc-interstitial lung disease are presented.

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7